# Role of Lactoferrin in Prevention of Ventilator Associated Pneumonia in Neonates.

> **NCT07255742** · NA · COMPLETED · sponsor: **Dalia Mohamed Salah** · enrollment: 50 (actual)

## Conditions studied

- Ventilator Associated Pneumonia

## Interventions

- **DIETARY_SUPPLEMENT:** Lactoferrin in prevention of VAP
- **OTHER:** Control

## Key facts

- **NCT ID:** NCT07255742
- **Lead sponsor:** Dalia Mohamed Salah
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-08-01
- **Primary completion:** 2025-12-01
- **Final completion:** 2025-12-04
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2026-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07255742

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07255742, "Role of Lactoferrin in Prevention of Ventilator Associated Pneumonia in Neonates.". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT07255742. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*